This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Essex Property (ESS) Q2 FFO & Revenues Beat, '23 View Revised
by Zacks Equity Research
Essex Property's (ESS) Q2 results reflect improving same-property net operating income. The company has also revised its 2023 projections.
Pebblebrook Hotel (PEB) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 10.71% and 0.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
UDR Q2 FFOA and Revenues Miss Estimates, '23 View Revised
by Zacks Equity Research
UDR's Q2 results reflect a year-over-year rise in revenues, driven by healthy operating trends and past accretive external growth investments. The company has also revised its 2023 outlook.
Mid-America Apartment (MAA) Q2 FFO & Revenues Beat Estimates
by Zacks Equity Research
Mid-America Apartment's (MAA) Q2 core FFO & revenues outpace estimates. Results reflect an increase in the average effective rent per unit for the same-store portfolio.
Highwoods (HIW) Q2 FFO Beat Estimates, Revises '23 View
by Zacks Equity Research
Highwoods' (HIW) Q2 results reflect a year-over-year increase in the top line on rent growth. However, a fall in occupancy acted as a dampener.
SITE Centers (SITC) Stock Declines 3.7% Despite Q2 FFO Beat
by Zacks Equity Research
SITE Centers' (SITC) second-quarter results beat estimates. The performance is aided by growth in annualized base rent and healthy leasing activity. It also revises its 2023 outlook.
Alexandria's (ARE) FFO & Revenues Surpass Estimates in Q2
by Zacks Equity Research
Alexandria's (ARE) Q2 results outperform estimates on solid rental rate growth and healthy leasing activity. It narrows its 2023 adjusted FFO per share outlook.
Prologis (PLD) Q2 FFO Surpass Estimates
by Zacks Equity Research
Prologis (PLD) delivered FFO and revenue surprises of 8.93% and 0.75%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
American Tower (AMT) Rides on Wireless Demand, Acquisitions
by Zacks Equity Research
American Tower (AMT) is well-poised to gain from the rising demand for wireless connectivity and its strategic acquisitions despite customer concentration woes and a high interest rate environment.
Are Options Traders Betting on a Big Move in Host Hotels (HST) Stock?
by Zacks Equity Research
Investors need to pay close attention to Host Hotels (HST) stock based on the movements in the options market lately.
Why You Should Retain Highwoods Properties (HIW) Stock for Now
by Zacks Equity Research
Healthy Sun Belt office market fundamentals, disciplined capital-recycling program and solid balance sheet position bode well for Highwoods Properties (HIW) amid stiff competition and elevated interest rates.
Here's Why Ventas (VTR) is an Apt Pick for Your Portfolio
by Zacks Equity Research
A rise in healthcare spending by senior citizens, accretive investments in the R&I business and office segment, and a solid balance sheet imply an optimistic near-term scenario for Ventas (VTR).
Alexandria (ARE) Recapitalizes San Diego Property at $981/RSF
by Zacks Equity Research
In sync with its capital-recycling strategy, Alexandria (ARE) and its JV partner divest 70% interest in 9625 Towne Centre Drive, fully leased to Takeda, in San Diego's UTC submarket at $981 per RSF.
Host Hotels (HST) Gains 12% in 3 Months: Will the Trend Last?
by Zacks Equity Research
Healthy operating performance amid improving demand, capital-recycling efforts and a robust balance sheet position are likely to continue driving Host Hotels' (HST) stock in the near term.
3 Stocks to Watch on Dividend Hikes Amid High Volatility
by Zacks Equity Research
Investors may keep a tab on stocks like NFG, HST and CASY which have lately hiked their dividend payments.
Why You Should Retain Boston Properties (BXP) Stock for Now
by Zacks Equity Research
Demand for high-quality office spaces, expansion efforts and a solid balance sheet bode well for Boston Properties (BXP) despite a choppy macroeconomic landscape and high interest rate environment.
Alexandria (ARE) Divests 5 Non-Core Properties for $365M
by Zacks Equity Research
Keeping up with its capital-recycling strategy, Alexandria (ARE) announces the disposition of five non-core assets in Greater Boston, spanning 428,663 rentable square feet, for $365 million.
Vornado (VNO) Inks 53K Sq.Ft. Lease With Life Time at PENN 1
by Zacks Equity Research
Vornado (VNO) leases more than 53,000 square feet on the first three floors of its PENN 1 property, strategically located next to Madison Square Garden in New York City, to Life Time.
Host Hotels (HST) Rewards Investors With a Dividend Raise
by Zacks Equity Research
Amid the improving lodging industry fundamentals, Host Hotels (HST) raises its dividend by 25% sequentially. Its decent cash flows and solid balance sheet are likely to support the latest hike.
5 Stocks With Recent Dividend Hike to Avert Rate Hike Fears
by Nalak Das
Dividend-paying stocks should be in demand as investors try to safeguard their portfolios. Five such stocks are: CAT, BBD, ITUB, HST, and WRB.
Should You Retain Ventas (VTR) Stock in Your Portfolio Now?
by Zacks Equity Research
Ventas (VTR) stands to gain from a diverse healthcare real estate portfolio, rebounding senior housing market and biopharma opportunities. Yet, tenant concentration and high interest rates remain concerns.
Here's Why You Should Retain Crown Castle (CCI) Stock for Now
by Zacks Equity Research
Solid demand for tower leasing amid global 5G deployment efforts by wireless carriers is likely to aid Crown Castle (CCI), though high interest rates and consolidation in the wireless industry are key woes.
Medical Properties (MPW) Disposes of 7 Australian Hospitals
by Zacks Equity Research
Marking the first phase of the two-part sale of its Australian real estate investments, Medical Properties (MPW) sells seven Australian hospitals for AUD$730 million.